LIGAND PHARMACEUTICALS INCORPORATED
(NASDAQ:LGND)|
2.71 +0.19 (7.54%) 1:23ET Delayed |
|
|
|
- Compare LGND with:
- View: Line | Candlestick
Company Profile
LIGAND PHARMACEUTICALS INCORPORATED
10275 Science Center Drive
San Diego, CA 92121-1117
United States - Map
Phone: (858) 550-7500
Fax: (858) 550-1826
Website: www.ligand.com
State of incorporation: Delaware
CEO: John L. Higgins
Employees: 59
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
Dev drugs that regulate hormone-activated receptor
An early-stage biotech company that focuses on discovering and developing new drugs that address critical unmet medical needs in the areas of thrombocytopenia, anemia, cancer, hormone-related diseases, osteoporosis and inflammatory diseases
Recent news for LGND
-
EDGAR Online - Dec 24 2008 at 4:57 ET
-
Ligand Completes Pharmacopeia Acquisition
Business Wire - Dec 23 2008 at 4:43 ET
-
LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online - Dec 22 2008 at 4:36 ET
-
UPDATE - Ligand licenses platelet-booster to Glaxo
Reuters - Dec 18 2008 at 9:00 ET
-
Briefing.com - Dec 18 2008 at 8:01 ET
-
Business Wire - Dec 18 2008 at 8:00 ET
-
Business Wire - Dec 08 2008 at 8:05 ET
-
Glaxo says oral drug raises blood platelet counts
Reuters - Dec 06 2008 at 11:00 ET
-
PR Newswire - Dec 06 2008 at 11:00 ET
-
Ecolab Insider Sells $827.7 Million Worth
TheStreet.com - Dec 04 2008 at 9:17 ET
